HPV-associated moderately differentiated squamous cell carcinoma of the cervix with pathologically confirmed bladder invasion and radiologically presumed adrenal metastasis in a patient with prior lung adenocarcinoma resection: a rare case report and clinical discussion - Report - MDSpire

HPV-associated moderately differentiated squamous cell carcinoma of the cervix with pathologically confirmed bladder invasion and radiologically presumed adrenal metastasis in a patient with prior lung adenocarcinoma resection: a rare case report and clinical discussion

  • By

  • Yaxiong Tang

  • Yanbo Dai

  • Min Jing

  • Kang Wang

  • July 10, 2026

  • 0 min

Share

Moderately Differentiated Squamous Cell Carcinoma of the Cervix Associated with HPV

Background

Cervical squamous cell carcinoma (CSCC) is a significant health concern, being the fourth most common cancer in women globally. Bladder invasion by CSCC is rare, occurring in only 5%-8% of cases, and often leads to misdiagnosis as primary urologic disease. Understanding the presentation and diagnostic challenges of CSCC is crucial for timely and appropriate treatment.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

  • A 74-year-old woman presented with obstructive uropathy due to bladder invasion by CSCC.
  • Initial symptoms included anuria, bilateral hydronephrosis, and fever, leading to acute kidney injury.
  • Pathological confirmation of bladder invasion was achieved through transurethral biopsy showing invasive squamous cell carcinoma.
  • Immunohistochemistry revealed a CK7+/CK20−/P63+/p16+ profile, aiding in the diagnosis.
  • The patient was diagnosed with clinical FIGO stage IVB due to bladder invasion and suspected adrenal metastasis.
  • Early palliative urinary diversion provided temporary renal function improvement.

Clinical Implications

Healthcare providers should consider gynecologic malignancies in female patients presenting with unexplained urinary symptoms.

Conclusion

This case highlights the diagnostic complexities of CSCC presenting with urinary symptoms.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Small cell carcinoma in a bladder diverticulum: a rare case report and literature review
  2. Frontiers in Oncology, 2026 -- Synchronous primary HPV-associated squamous cell carcinomas of the cervix and fallopian tube: a case report
  3. Frontiers in Oncology, 2026 -- Bladder sarcoma treated with radical cystectomy and adjuvant epirubicin and ifosfamide chemotherapy: a case report
  4. Cancer of the cervix uteri: 2025 update - PMC
  5. Preoperative staging of cervical cancer: time to shift from cystoscopy to MRI | European Radiology | Springer Nature Link
  6. Outcomes of Stage IVA Cervical Cancer Treated with Radiotherapy: A Systematic Review and Meta-Analysis - ScienceDirect
  7. Frontiers in Oncology — A Case Report of Primary Mucinous Adenocarcinoma of the Bladder and Literature Review
  8. Pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer: Final analysis results of the phase 3, randomized, double-blind ENGOT-cx11/GOG-3047/KEYNOTE-A18 study.
  9. Distant disease assessment and suspected adrenal metastasis: Current nuclear medicine guidance.
  10. Cancer of the cervix uteri: 2025 update - PMC
  11. Preoperative staging of cervical cancer: time to shift from cystoscopy to MRI | European Radiology | Springer Nature Link
  12. Outcomes of Stage IVA Cervical Cancer Treated with Radiotherapy: A Systematic Review and Meta-Analysis - ScienceDirect
  13. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
  14. Treatment advances across the cervical cancer spectrum | Nature Reviews Clinical Oncology
  15. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors | European Journal of Endocrinology | Oxford Academic
  16. Frontiers | An interpretable 18F-FDG PET/CT-based radiomics model for predicting sub-3cm solitary adrenal metastases in cancer patients

Original Source(s)

Related Content